로딩 중…
지수 로딩 중…
Apogee Therapeutics, Inc.
APGE· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
$90.35+2.17%
2026-06-18
Price Chart
Apogee Therapeutics, Inc.+119.40%
Financials
No data
※ FY = Fiscal Year
Investment Metrics(as of 2026-06-18)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | $6.81B |
| Revenue | $0.00 |
| Net Income | $-275M |
| Total Assets | $1.29B |
| Net Assets | $1.26B |
| Value | |
| P/B | 5.42x |
| FCF Yield | -3.46% |
| Profitability | |
| ROE | -21.87% |
| ROA | -21.23% |
| Financial Health | |
| Debt Ratio | 3.01% |
| Total Debt | $8M |
| FCF | $-235M |
| Cash | $452M |
| Current Ratio | 32.59x |
| Performance | |
| 1Y Return | 119.40% |
| 1M Return | 15.43% |
| From 52W High | -5.21% |
| 1Y MDD | -26.99% |
| Trading | |
| Volume | 1,685,401 shares |
| Trading Value | $151M |
| Per Share | |
| EPS | $-4.22 |
| BPS | $14.89 |